Selling And Administration Expenses Lave om Dato
AbbVie USD 3.61B 273M 2023-12
Abbott USD 2.69B 10M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Avrobio USD 6.26M 1.68M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
J&J USD 5.81B 410M 2023-12
Merck USD 2.75B 272M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Takeda JPY 252.95B 4.84B 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Xencor USD 15.48M 2.98M 2023-12



Karyopharm Therapeutics Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.